Hemostat Laboratories is categorized under Blood Derivatives in Dixon, CA and active since 1980.
Hemostat Laboratories was established in 1980, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Blood Derivatives business, which does work in the B2B market, and is classified as a Blood Derivatives, under code number 3391120 by the NAICS.
If you are seeking more information, feel free to contact James Mcelgott, President at the company’s single location by writing to 515 Industrial Way, Dixon, California CA 95620 or by phoning (707) 678-9594. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hemostat Laboratories |
| Contact Person: | James Mcelgott, President |
| Address: | 515 Industrial Way, Dixon, California 95620 |
| Phone Number: | (707) 678-9594 |
| Website Address: | hemostat.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1980 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Blood Derivatives |
| SIC Code: | 2836 |
| NAICS Code: | 3391120 |
| Share This Business: |
Hemostat Laboratories was started in 1980 to provide professional Blood Derivatives under the SIC code 2836 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact James Mcelgott, President for inquiries that concern Hemostat Laboratories by calling the company number (707) 678-9594, as your correspondence is most welcome. Additionally, the physical location of the single location of Hemostat Laboratories can be found at the coordinates 38.45896,-121.81592 as well as the street address 515 Industrial Way in Dixon, California 95620.
For its online presence, you may visit Hemostat Laboratories’s website at hemostat.com and engage with its social media outlets through on Twitter and on Facebook.